Tue, December 3, 2019
Mon, December 2, 2019
Fri, November 29, 2019
Wed, November 27, 2019
Tue, November 26, 2019
Mon, November 25, 2019
Fri, November 22, 2019
Thu, November 21, 2019
Wed, November 20, 2019
Tue, November 19, 2019
Mon, November 18, 2019
Fri, November 15, 2019
Thu, November 14, 2019
Wed, November 13, 2019

David Lebovitz Maintained (ASND) at Buy with Increased Target to $134 on, Nov 20th, 2019


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. th-increased-target-to-134-on-nov-20th-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Lebovitz of Morgan Stanley, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $128 to $134 on, Nov 20th, 2019.

David has made no other calls on ASND in the last 4 months.



There are 2 other peers that have a rating on ASND. Out of the 2 peers that are also analyzing ASND, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Liana Moussatos of "Wedbush" Maintained at Buy with Decreased Target to $186 on, Tuesday, October 22nd, 2019
  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $152 on, Thursday, August 29th, 2019

Publication Contributing Sources